Gastroesophageal Reflux Disease News and Research

RSS

Gastroesophageal reflux disease (GERD) is a more serious form of gastroesophageal reflux (GER), which is common. GER occurs when the lower esophageal sphincter (LES) opens spontaneously, for varying periods of time, or does not close properly and stomach contents rise up into the esophagus. GER is also called acid reflux or acid regurgitation, because digestive juices—called acids—rise up with the food. The esophagus is the tube that carries food from the mouth to the stomach. The LES is a ring of muscle at the bottom of the esophagus that acts like a valve between the esophagus and stomach.

Incidence of esophageal cancer linked to GERD rises six-fold in recent decades

Esophageal cancer is one of the fastest-growing and deadliest cancers in the U.S. According to the American Cancer Society, an estimated 17,000 new cases of esophageal cancer will be diagnosed in 2015. Incidence of adenocarcinoma, a type of esophageal cancer linked to GERD (gastroesophageal reflux disease) has risen six-fold in recent decades.

21 Apr 2015

Medigus announces completion of three MUSE procedures for GERD treatment in Italy

Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced the completion of three MUSE procedures in Italy by renowned gastroenterologist, Professor Pier Alberto Testoni, Director of Gastroenterology and Digestive Endoscopy IRCCS at San Raffaele Hospital in Milan.

18 Mar 2015

MGH study suggests that bariatric surgery can reduce risk of asthma attacks

A study led by Massachusetts General Hospital investigators suggests that bariatric surgery can significantly reduce the risk of asthma attacks - also called exacerbations - in obese patients with asthma.

16 Mar 2015

New standardized approach for feeding infants in NICU improves growth of babies

A new standardized approach for feeding infants in the neonatal intensive care unit (NICU) helps babies attain full oral feeds sooner, improves their growth and sends them home sooner.

3 Mar 2015

St. John Hospital first in Michigan to offer new alternative treatment for acid reflux disease

St. John Hospital is among the first in the state and the only site in southeast Michigan to offer a new alternative treatment for patients with acid reflux disease.

10 Feb 2015

Childhood obesity linked to higher risk of developing oesophageal cancer in later life

Overweight children may be at higher risk of oesophageal (gullet) cancer when they grow up than their slimmer friends, according to research published this week in the British Journal of Cancer.

6 Feb 2015

Gastroenterology publishes landmark data from RESPECT study of Transoral Incisionless Fundoplication procedure

EndoGastric Solutions announces that Gastroenterology, the official journal of the American Gastroenterological Association Institute and the most prominent journal in the field of gastrointestinal disease, has published landmark data from the first-ever blinded, randomized, sham- and placebo-controlled clinical study of the Transoral Incisionless Fundoplication (TIF) procedure.

22 Jan 2015

First two patients enrolled in AGA’s GERD Registry successfully undergo treatment

The American Gastroenterological Association (AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry — which seeks to compare laparoscopic surgery to an incisionless procedure to treat gastroesophageal reflux disease (GERD) — have successfully undergone treatment.

23 Dec 2014

AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry

23 Dec 2014

US registry data shows long-term positive outcomes for GERD patients choosing TIF procedure

EndoGastric Solutions announced publication of US registry data showing that long-term gastroesophageal reflux disease (GERD) sufferers who underwent an incisionless procedure maintained symptom relief without the need to take proton pump inhibitor medicines for two years.

30 Oct 2014

Statins reduce patient's risk of developing Barrett's esophagus

Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.

24 Jul 2014

RD Biomed announces Chinese distribution agreement for reflux diagnostic tool Peptest

RD Biomed, the Yorkshire medical technology company, has announced a Chinese distribution agreement for its world-leading reflux diagnostic tool Peptest.

8 Jul 2014

LINX Reflux Management System safe for patients suffering from GERD, shows new data

Torax Medical today announced the release of new data from two leading U.S. medical centers that further establishes the LINX Reflux Management System as a safe and effective procedure for patients suffering from gastroesophageal reflux disease (GERD).

1 Jul 2014

FSC Laboratories acquires exclusive marketing rights for Aciphex Sprinkle in the U.S.

FSC Therapeutics, LLC, today announced that the Company has entered into a transaction with Eisai Inc. to acquire exclusive U.S. marketing rights for AcipHex® Sprinkle™ (rabeprazole sodium), Delayed-Release Capsules, 5 mg and 10 mg, for the treatment of Gastroesophageal Reflux Disease (GERD) in children 1 to 11 years of age for up to 12 weeks.

30 Jun 2014

Effects of radiofrequency ablation and complete endoscopic resection are equal in dysplastic Barrett's esophagus

According to a new systematic review article, radiofrequency ablation and complete endoscopic resection are equally effective in the short-term treatment of dysplastic Barrett's esophagus, but adverse event rates are higher with complete endoscopic resection.

22 May 2014

Oral health: The gateway to your overall health

If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your oral health and your overall health.

25 Apr 2014

Access provides update on new formulation of anti-inflammatory drug amlexanox

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called LexaGard™, for the treatment of inflammatory and ulcerative conditions of the esophagus.

8 Apr 2014

Study confirms safety of LINX Reflux Management System for GERD treatment

Millions of Americans suffer from Gastroesophageal Reflux Disease (GERD), a chronic, often progressive disease that can cause debilitating symptoms and lead to serious complications including pre-cancerous Barrett's esophagus and esophageal cancer.

2 Apr 2014

Infants who experience ALTEs have abnormal regulation of esophageal function

About 1 percent of all emergency room visits are prompted by near-death experiences in infants, such as extended periods without breathing or sudden changes in skin pallor or muscle tone. What causes these frightening experiences is often unknown, but the result can be long hospital stays and neurological impairment.

29 Mar 2014

Ironwood Pharmaceuticals starts Phase IIa clinical study of IW-3718 for gastroesophageal reflux disease

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that dosing has begun in its Phase IIa clinical study of its investigational compound IW-3718 in patients suffering from gastroesophageal reflux disease (GERD) who have not responded adequately to treatment with a proton pump inhibitor (PPI). Data are expected in the first half of 2015.

18 Mar 2014